Microangiopathic haemolytic anaemia secondary to lupus nephritis: An important differential diagnosis of thrombotic thrombocytopenic purpura

Lupus

Volumn 16, Issue 5, 2007, Pages 358-362

  Hunt, Beverley J ^a,d   Tueger, S ^a   Pattison, J ^b   Cavenagh, J ^c   D'Cruz, D P ^a  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^b GUY S HOSPITAL   (United Kingdom)

^c ROYAL LONDON HOSPITAL   (United Kingdom)

^d ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Lupus; Thrombotic thrombocytopenic purpura

Indexed keywords

ANTICONVULSIVE AGENT; ANTIHYPERTENSIVE AGENT; CYCLOPHOSPHAMIDE; DIURETIC AGENT; IMMUNOGLOBULIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RITUXIMAB; VINCRISTINE; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ADULT; ARTICLE; CASE REPORT; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; ENZYME BLOOD LEVEL; FEMALE; HEMOLYTIC UREMIC SYNDROME; HUMAN; LUPUS ERYTHEMATOSUS NEPHRITIS; MALIGNANT HYPERTENSION; PRIORITY JOURNAL; PROTEINURIA; SYMPTOM; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ADULT; ANEMIA; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LUPUS NEPHRITIS; PURPURA, THROMBOTIC THROMBOCYTOPENIC;

EID: 34447519038     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203307077151     Document Type: Article

References (20)

1. Levine S, Shearn MA. Thrombotic thrombocytopenic purpura and systemic lupus erythematosus. Arch Intern Med 1964; 113: 826-836.
2. Tsai HM, Lian EC. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med 1998; 339: 1585-1594.
3. Fujikawa K, Suzuki H, McMullen B, Chung D. Purification of human von Willebrand factor-cleaving protease and its identification as a new member of the metalloproteinase family. Blood 2001; 98: 1662-1666.
4. Gerritsen HE, Robles R, Lammle B, Furlan M. Partial amino acid sequence of purified von Willebrand factor-cleaving protease. Blood 2001; 98: 1654-1661.
5. Furlan M, Robles R, Galbusera M et al. Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and hemolytic-uremic syndrome. N Engl J Med 1998; 339: 1578-1584.
6. Levy GG, Nichols WC, Lian EC et al. Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature 2001; 413: 488-494.
7. Vaidya S, Abul-ezz S, Lipsmeyer E. Thrombotic thrombocytopenic purpura and Systemic lupus erythematosis . Scand J Rheumatol 2001; 30: 308-310.
8. Gatenby PA, Smith H, Kirwan P, Lauer CS. Systemic lupus erythematosus and thrombotic thrombocytopenic purpura: A case report and review of relationship. J Rheumatol 1981; 8: 504-508.
9. Blake JS, Butani L. Rapidly progressive lupus glomerulonephritis and concomitant microangiopathy in an adolescent. Lupus 2002; 11: 533-535.
10. Hamasaki K, Mimura T, Kanda H et al. Systemic lupus erythematosus and thrombotic thrombocytopenic purpura: a case report and literature review. Clin Rheumatol 2003; 22: 355-358.
11. Sakarcan A, Stallworth J. Systemic lupus erythematosus and thrombotic thrombocytopenic purpura: a case and review. Pediatr Nephrol 2001; 16: 672-674.
12. Hunt L, Xiaoning Li, Judith James et al. Thrombotic thrombocytopenic purpura (TTP) and systemic lupus erythematosus (SLE): distinct but potentially overlapping syndromes. Blood 2004; 104: 245a.
13. Pereira A, Mazzara R, Monteagudo J et al. Thrombotic thrombocytopenic purpura/hemolytic uremic syndrome: a multivariate analysis of factors predicting the response to plasma exchange. Ann Hematol 1995; 70: 319-323.
14. Rock G, Kelton JG, Shumak KH, Buskard NA, Sutton DM, Benny WB. Laboratory abnormalities in thrombotic thrombocytopenic purpura. Canadian Apheresis Group. Br J Haematol 1998; 103: 1031-1036.
15. Rock GA, Shumak KH, Buskard NA et al. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group. N Engl J Med 1991; 325: 393-397.
16. Akaogi J, Akasaka N, Yamada H, Hama N, Satoh M, Nichols C, Ozaki S. Intravenous cyclophosphamide therapy in a case with refractory thrombotic microangiopathic hemolytic anemia and SLE. Clin Rheumatol 2004; 23: 541-543.
17. Chan TM, Li FK, Tang CS et al. Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group. N Engl J Med 2000; 343: 1156-1162.
18. Briggs WA, Choi MJ, Scheel PJ Jr. Successful mycophenolate mofetil treatment of glomerular disease. Am J Kidney Dis 1998; 31: 213-217.
19. Glicklich D, Acharya A. Mycophenolate mofetil therapy for lupus nephritis refractory to intravenous cyclophosphamide. Am J Kidney Dis 1998; 32: 318-322.
20. Dooley MA, Cosio FG, Nachman PH et al. Mycophenolate mofetil therapy in lupus nephritis: clinical observations. J Am Soc Nephrol 1999; 10: 833-839.